Plasma PLTP activity is inversely associated with HDL-C levels

Nutrition and Metabolism

Volumn 6, Issue , 2009, Pages

  Chen, Xueying ^a   Sun, Aijun ^a   Mansoor, Ather ^b   Zou, Yunzeng ^a   Ge, Junbo ^a   Lazar, Jason M ^b   Jiang, Xian Cheng ^c  

^a FUDAN UNIVERSITY   (China)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID LIVER LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHOSPHOLIPID TRANSFER; PLASMA; POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 74049135730     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-6-49     Document Type: Article

References (36)

1. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. A Schlitt C Bickel P Thumma S Blankenberg HJ Rupprecht J Meyer XC Jiang, Arterioscler Thromb Vasc Biol 2003 23 1857 1862 10.1161/01.ATV.0000094433.98445.7F 12947020
2. Serum phospholipid transfer protein activity and genetic variation of the PLTP gene. E Tahvanainen M Jauhiainen H Funke E Vartiainen J Sundvall C Ehnholm, Atherosclerosis 1999 146 107 115 10.1016/S0021-9150(99)00140-9 10487493
3. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. RP Dullaart WJ Sluiter LD Dikkeschei K Hoogenberg A Van Tol, Eur J Clin Invest 1994 24 188 194 10.1111/j.1365-2362.1994.tb00987.x 8033953
4. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients. SC Riemens A van Tol WJ Sluiter RP Dullaart, Diabetologia 1998 41 929 934 10.1007/s001250051009 9726595
5. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. HM Colhoun LM Scheek MB Rubens T Van Gent SR Underwood JH Fuller A Van Tol, Diabetes 2001 50 652 659 10.2337/diabetes.50.3.652 11246887
6. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus. KC Tan SW Shiu Y Wong S Tam, Atherosclerosis 2005 178 365 370 10.1016/j.atherosclerosis.2004.09.005 15754464
7. PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. SJ Murdoch MC Carr JE Hokanson JD Brunzell JJ Albers, J Lipid Res 2000 41 237 244 10681407
8. Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity. MC Cheung RH Knopp B Retzlaff H Kennedy G Wolfbauer JJ Albers, Biochim Biophys Acta 2002 1587 53 59 12009424
9. Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity. J Huuskonen M Ekstrom E Tahvanainen A Vainio J Metso P Pussinen C Ehnholm VM Olkkonen M Jauhiainen, Atherosclerosis 2000 151 451 461 10.1016/S0021-9150(99)00429-3 10924722
10. Haplotypes in the phospholipid transfer protein gene are associated with obesity-related phenotypes: the Quebec Family Study. Y Bosse L Bouchard JP Despres C Bouchard L Perusse MC Vohl, Int J Obes (Lond) 2005 29 1338 1345 10.1038/sj.ijo.0803010 15953936
11. Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia. BE Aouizerat MB Engler Y Natanzon M Kulkarni J Song C Eng J Huuskonen C Rivera A Poon M Bensley A Sehnert C Zellner M Malloy J Kane CR Pullinger, J Lipid Res 2006 47 787 793 10.1194/jlr.M500476-JLR200 16388083
12. Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia. MB Engler CR Pullinger MJ Malloy Y Natanzon MV Kulkarni J Song C Eng J Huuskonen C Rivera A Poon M Bensley A Sehnert C Zellner J Kane BE Aouizerat, Metabolism 2008 57 1719 1724 10.1016/j.metabol.2008.07.031 19013296
13. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. AR Tall S Krumholz T Olivecrona RJ Deckelbaum, J Lipid Res 1985 26 842 851 4031662
14. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. M Jauhiainen J Metso R Pahlman S Blomqvist A van Tol C Ehnholm, J Biol Chem 1993 268 4032 4036 8440695
15. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. R van Haperen A van Tol P Vermeulen M Jauhiainen T van Gent P van den Berg S Ehnholm F Grosveld A van der Kamp R de Crom, Arterioscler Thromb Vasc Biol 2000 20 1082 1088 10764677
16. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. B Foger S Santamarina-Fojo RD Shamburek CL Parrot GD Talley HB Brewer Jr, J Biol Chem 1997 272 27393 27400 10.1074/jbc.272.43.27393 9341191
17. Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism. R van Haperen H Samyn T van Gent AJ Zonneveld M Moerland F Grosveld H Jansen GM Dallinga-Thie A van Tol R de Crom, Biochim Biophys Acta 2009 1791 1031 1036 19524061
18. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. R van Haperen A van Tol T van Gent L Scheek P Visser A van der Kamp F Grosveld R de Crom, J Biol Chem 2002 277 48938 48943 10.1074/jbc.M209128200 12372822
19. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. XC Jiang C Bruce J Mar M Lin Y Ji OL Francone AR Tall, J Clin Invest 1999 103 907 914 10.1172/JCI5578 10079112
20. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. S Qin K Kawano C Bruce M Lin C Bisgaier AR Tall X Jiang, J Lipid Res 2000 41 269 276 10681411
21. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. D Yan M Navab C Bruce AM Fogelman XC Jiang, J Lipid Res 2004 45 1852 1858 10.1194/jlr.M400053-JLR200 15258196
22. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. S Lusa M Jauhiainen J Metso P Somerharju C Ehnholm, Biochem J 1996 313 Pt 1 275 282 8546695
23. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. KA Rye M Jauhiainen PJ Barter C Ehnholm, J Lipid Res 1998 39 613 622 9548593
24. The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. D Masson XC Jiang L Lagrost AR Tall, J Lipid Res 2009 50 Suppl 201 206 10.1194/jlr.R800061-JLR200 19023137
25. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. JH Tollefson S Ravnik JJ Albers, J Lipid Res 1988 29 1593 1602 2854151
26. Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo. K Kawano SC Qin M Lin AR Tall XC Jiang, J Biol Chem 2000 275 29477 29481 10.1074/jbc.M003523200 10893412
27. Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice. A Schlitt J Liu D Yan M Mondragon-Escorpizo AJ Norin XC Jiang, Biochim Biophys Acta 2005 1733 187 191 15863365
28. Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice. L Shelly L Royer T Sand H Jensen Y Luo, J Lipid Res 2008 49 773 781 10.1194/jlr.M700336-JLR200 18198166
29. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. XC Jiang AR Tall S Qin M Lin M Schneider F Lalanne V Deckert C Desrumaux A Athias JL Witztum L Lagrost, J Biol Chem 2002 277 31850 31856 10.1074/jbc.M205077200 12105225
30. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. XP Yang D Yan C Qiao RJ Liu JG Chen J Li M Schneider L Lagrost X Xiao XC Jiang, Arterioscler Thromb Vasc Biol 2003 23 1601 1607 10.1161/01.ATV.0000085841.55248.13 12855484
31. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. JF Oram G Wolfbauer AM Vaughan C Tang JJ Albers, J Biol Chem 2003 278 52379 52385 10.1074/jbc.M310695200 14559902
32. Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells. M Lee-Rueckert R Vikstedt J Metso C Ehnholm PT Kovanen M Jauhiainen, J Lipid Res 2006 47 1725 1732 10.1194/jlr.M600051-JLR200 16687660
33. Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography. E Cavusoglu JD Marmur S Chhabra V Chopra C Eng XC Jiang, Atherosclerosis 2009 207 261 265 10.1016/j.atherosclerosis.2009.04.011 19446293
34. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. R de Vries GM Dallinga-Thie AJ Smit BH Wolffenbuttel A van Tol RP Dullaart, Diabetologia 2006 49 398 404 10.1007/s00125-005-0088-0 16374627 (Pubitemid 43185411)
35. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. XC Jiang S Qin C Qiao K Kawano M Lin A Skold X Xiao AR Tall, Nat Med 2001 7 847 852 10.1038/89977 11433351
36. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J Lie R de Crom T van Gent R van Haperen L Scheek I Lankhuizen A van Tol, J Lipid Res 2002 43 1875 1880 10.1194/jlr.M200166-JLR200 12401886